Latest news
Immune Mediated Disease Therapeutics Developer Attovia Therapeutics Debuts on Nasdaq - Macau BusinessMacau Business · Fri, 07 Aug 2026 07:00:00 GMTATTO Stock News Today | Earnings, Events & Price Alerts - Intellectia AIIntellectia AI · Thu, 06 Aug 2026 17:39:32 GMTAttovia jumps on Nasdaq debut after upsizing IPO to $289 million - The Pharma LetterThe Pharma Letter · Thu, 06 Aug 2026 15:18:54 GMTAttovia IPO Proceeds Will Advance Three Immune-Mediated Candidates - Stock TitanStock Titan · Thu, 06 Aug 2026 09:57:00 GMTImmunotherapy Startup Attovia Lists on Nasdaq: IPO Raises $289 Million, First-Day Market Cap Tops $900 Million - finance.biggo.comfinance.biggo.com · Thu, 06 Aug 2026 08:26:00 GMTU.S. Stocks Move | Biotech Company Attovia Therapeutics (ATTO.US) Debuts on Nasdaq, Closing Up 28.82% on First Trading Day - MoomooMoomoo · Wed, 05 Aug 2026 22:51:40 GMTSantander Bank (SAN.US) expands its U.S. business with a crucial piece! $12 billions acquisition of Webster Financial (WBS.US) approved by the Federal Reserve - BitgetBitget · Wed, 05 Aug 2026 22:42:13 GMTIPO momentum continues with Attovia's bumped-up $289M raise - FirstWord PharmaFirstWord Pharma · Wed, 05 Aug 2026 22:01:57 GMT